Results 151 to 160 of about 12,593 (182)

Cellular Senescence: Emerging Therapeutic Target for Idiopathic Pulmonary Fibrosis Pathogenic Mechanisms and Therapeutic Strategies. [PDF]

Biomol Ther (Seoul)
Suwanprakorn N, Choi Y, Choi YS, Yoo HJ, Yang SG.   +4 more
europepmc   +1 more source

Potential Therapeutic Strategies for Steatosis, Oxidative Stress, Inflammation, and Fibrosis in Liver Disease. [PDF]

Int J Mol Sci
Muriel P, Vargas-Pozada EE, Márquez-Quiroga LV, Ramos-Tovar E.   +3 more
europepmc   +1 more source

Multi-omics insights into the mechanisms and prognosis of IPF. [PDF]

Genes Environ
Chen D, Chen Q, Liu H, Wang Z, Liu X, Hu J, Lu C.   +6 more
europepmc   +1 more source

Targeting Inflammatory and Oxidative Pathways in Idiopathic Pulmonary Fibrosis: Synergistic Effects of Quercetin and Pirfenidone in Modulating Nrf2/PPAR-γ and TLR-4/NF-κB Pathways. [PDF]

Pharmacol Res Perspect
Wanas H, Khalifa AK, Elbadawy HM, Hamoud AE, Almikhlafi MA, Albadawi EA, Alghabban HM, Owaydhah WH, Galal AM.   +8 more
europepmc   +1 more source

Inhibition of runt related transcription factor 1 with Ro24-7429 improves lung function in experimental models of idiopathic pulmonary fibrosis. [PDF]

Sci Rep
Hirsch TI, Miller WP, Tsikis ST, Arevalo-Alquichire SJ, Kaplan BA, Barake KW, Gunawan AL, Vanderleest TE, Vijikumar A, Sanchez-Suarez J, Fligor SC, Wang SZ, Pan AS, Quigley M, Kamiya M, Kim EY, O'Hare M, Lennikov A, Kim LA, Puder M.   +19 more
europepmc   +1 more source

Global landscape for pulmonary fibrosis treatment: a data-driven perspective from clinical trials. [PDF]

BMC Pulm Med
Zhao C, Song C, Zhou Y, Luo J, Zheng S, Li X, Dang Y, Yang N, Kong J.   +8 more
europepmc   +1 more source

Systemic Autoimmune Rheumatic Disease-Associated Interstitial Lung Disease: A Pulmonary Perspective on Recent Guidelines. [PDF]

Adv Ther
Ozduygu G, Kaenmuang P, Guedes ABF, Amaral AF, Chaudhuri N.   +4 more
europepmc   +1 more source

Dual-mechanism inhalable nanocomposite restores the alveolar mucus barrier and enables deep-lesion delivery for synergistic treatment of pulmonary fibrosis. [PDF]

J Nanobiotechnology
Guo Z, Chen S, Dong S, Lu K, Shi J, Chen W, Liu D, Fu J, Zhu C, Li B, Long X.   +10 more
europepmc   +1 more source

Efficacy and Safety of Pirfenidone for Mitigation of Interstitial Lung Abnormalities in COVID-19 Patients: A Meta-Analysis. [PDF]

Can Respir J
Zhang Z, Fang X, Gao J, Sun H, Xu T, Wang J.   +5 more
europepmc   +1 more source

Effect of pirfenidone on plasma markers of collagen turnover in patients with heart failure, preserved left ventricular ejection fraction and myocardial fibrosis. [PDF]

Open Heart
Black N, Lewis G, Soltani F, Dodd S, Schelbert EB, Ravassa S, López B, González A, Cleland JG, Miller CA.   +9 more
europepmc   +1 more source